This Note will examine DTCA in the context of DTC telemedicine companies, with a focus on the proliferation of such advertisements on social media platforms. Part I discusses the intertwining forces that have led to the prevalence of DTC telehealth advertising on social media. Part II introduces the current regulatory scheme applicable to DTCA, and explains the First Amendment protections afforded to commercial speakers. Part III explores why DTC telemedicine companies are not subject to the regulations applicable to DTCA generally, as well as the implications stemming from the current lack of oversight. Finally, Part IV proposes a solution to address the current regulatory asymmetry while preserving the constitutional rights of advertisers.
"TikTok is Not Your Doctor: Reprioritizing Consumer Protection in Pharmaceutical Advertisement Regulation,"
Belmont Law Review: Vol. 11:
1, Article 6.
Available at: https://repository.belmont.edu/lawreview/vol11/iss1/6